Pharmaceuticals

Gilead and Others HIV Drug Anticompetitive Agreements Class Action

Anticompetitive efforts in the field of pharmaceuticals have become more sophisticated in recent years. This antitrust class action concerns combination antiretroviral therapy (cART) regimen drugs used by patients with human immunodeficiency virus (HIV), a condition that can lead to Acquired Immunodeficiency Syndrome (AIDS) and death. The complaint alleges that a number of companies have conspired  Read more

Lovenox/Enoxaparin Antitrust Settlement

Momenta Pharmaceuticals, Inc. and Sandoz, Inc. are settling an antitrust class action alleging that they conspired to keep the prices of Lovenox and its generic enoxaparin higher than they should have been by manipulating the generic approvals process. While Momenta did not create the drug, the complaint says the companies manipulated the process to bring  Read more

Avandia Use and Cardiovascular Injuries Settlement

GlaxoSmithKline, Inc. and GlaxoSmithKline, LLC are settling a class action centering on their drug Avandia. The complaint alleged that people who took Avandia suffered heart attacks or congestive heart failure or needed coronary artery bypass grafts or percutaneous coronary intervention.  Read more

Infants’ Tylenol Settlement

Johnson & Johnson Consumer, Inc. offers an Infants’ Tylenol product that purportedly differs from its Children’s Tylenol. However, it is agreeing to settle a class action taking issue with the representations on the Infants’ Tylenol packaging. The complaint alleged that the designation “Infants’” and the representation of a mother holding a baby misleads consumers into  Read more

Sanofi-Aventis Zantac/Generics Produce NDMA in the Body Class Action

Zantac is a brand-name form of ranitidine, a stomach-acid reduction drug. The complaint for this class action alleges that certain companies involved in the making or marketing of Zantac—Sanofi-Aventis US, LLC, Sanofi US Services, Inc., Chattem, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., and GlaxoSmithKline, LLC (GSK)—have been continuing to put out the drug despite knowing that  Read more

Zantac Contaminated with NDMA New York Class Action

If too many samples of a certain drug are found to be contaminated, shouldn’t sales of the drug be suspended until the contamination problem has been resolved? The complaint for this class action alleges that Sanofi-Aventis US, LLC, Sanofi US Services, Inc. and Chattem, Inc. have faield to pull their drug Zantac off the market,  Read more

Zantac High Levels of NDMA but No Recall Class Action

This complaint concerns a drug brand-named Zantac, and names as defendants maker Sanofi US, LLC, distributor Chattem, Inc., and sellers CVS Health Co. (formerly CVS Caremark) and Dollar Tree Stores, Inc. The complaint alleges that the drug contains “dangerously high levels or N-nitrosodimethylamine (NDMA).  Read more

Anda Opioid Distribution and Health Insurance Costs Florida Class Action

This complaint against another company that deals in opioids takes a different tack than most. The complaint claims that Anda, Inc., a distributor, through its careless handling of the drugs, has caused health insurance costs to go up.  Read more

Celgene Thalomid and Revlimid Antitrust Settlement

Celgene Corporation is paying $55 million to settle antitrust class actions about its drugs Thalomid and Revlimid. The complaints alleged that the company acted to keep generics of the drugs off the market for a time, forcing consumers to pay more for the drugs than they would have with open market competition.  Read more

Glumetza Diabetes Drug Antitrust Conspiracy Class Action

What’s a fair price for a thirty-day supply of the extended-release diabetes medicine Glumetza—generic name metformin? Is it $55 or $2,200? The complaint for this class action alleges that a number of companies conspired to limit the entry of generic versions of Glumetza to the market. The defendants in this antitrust suit are Bausch Health  Read more